-
-
Call more information
660-596-2224 -
Authors: Kumar G. Belani, MBBS, MS, FACA, FAAP, SAMBA-F; Ronald G. Pearl, MD, PhD, FASA, FCCM ASA Monitor November 2023, Vol. 87, 19. I view it [AI] as the most profound technology humanity will ever work on …. If you think about fire, electricity or the internet, it’s like that but I think even more profound. […]
Read MoreAuthors: Zachary Deutch, MD, FASA; Russ Armistead, MBA ASA Monitor November 2023, Vol. 87, 10–11. Behind every successful leader is a great support network! Pictured are members of the Armistead family cheering on the Wake Forest football team. Left to right: Mr. Armistead’s wife, daughter, granddaughter, son-in-law, and grandson. Many ASA members have interacted with members […]
Read MoreAuthor: Emily C. Raffensberger, M.S. Anesthesiology October 2023. I’m bound comfortably snug inside a cocoon of anesthesia. There’s nothing to see, to taste, to touch. Nothing hurts. Everything is starch and antiseptic. Out of the nothingness come pinpricks of sound. There is the hum of ventilation. I hear a voice say the phrase “wake up.” […]
Read MoreASA Monitor November 2023, Vol. 87, 18. Trends Flu vaccine shows strong protection again hospitalization in South America A Centers for Disease Control and Prevention (CDC) report released in September evaluated vaccine effectiveness during the March-September Southern Hemisphere influenza season. A human neutrophil (red) containing ingested Klebsiella pneumoniae (purple). Photo courtesy of NIAID. Based on data contributed by […]
Read MoreAuthors: William Amarquaye, PharmD et al Pract Pain Manag. 2023 March/April;22(2). With an unprecedented surge in psychostimulant-related deaths due to cross-contamination of illicitly manufactured fentanyl, here’s what prescribers and physicians need to know, including monitoring and mitigating risk, for their patients who use methamphetamine and cocaine. A Special Report. Background: It Started with Opioids The […]
Read More